The IPO Schedule For This Week In US

Posted by: : Paul EbelingPosted on: February 8, 2015 The IPO Schedule For This Week In US
 

The IPO Schedule For This Week In US

$AJX,  $SLWD, $ NVTA, $INOV, $ABMX, $AVNU, $EYEG, $REDX, $ITEK, $BLPH

Below is a look at the IPOs on the schedule for this week.

The IPO holdovers:

The 1st holdover from last week is Infraredx Inc., a cardiovascular imaging company working on the diagnosis and treatment of coronary artery disease. The company plans to offer 4-M/shares in an expected price range of 13 to 15 to raise $56-M at a market cap of nearly $200-M. Joint bookrunners for the offering are RBC Capital Markets, Canaccord Genuity and BMO Capital Markets. Co-managers are Oppenheimer and BTIG. Shares are listed as day-to-day and are to begin trading on the NAS under the symbol REDX.

The 2nd holdover is Eyegate Pharmaceuticals Inc., a clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company has lowered both its number of shares on offer and its price. Eyegate now plans to sell 800,000/shares at an expected price of 6 to raise $5-M at a market cap of $48.3-M. Joint bookrunners for the offering are Aegis Capital and Chardan Capital Markets. No date other than this week has been set for pricing. Shares will trade on the NAS under the symbol EYEG.

The 3rd holdover is Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and is expected to try again in this week. The company plans to offer 4.6-M/shares in an expected price range of 13 to 15 to raise $65-M at a market cap of $191.3-M. Joint bookrunners for the offering are Cowen, Piper Jaffray, Canaccord Genuity and Nomura Securities. Shares are listed as day-to-day, to begin trading on the NAS under the symbol ITEK.

The new IPO’s:

The 1st of the newly scheduled IPOs for this week is is AutoGenomics Inc., a commercial stage molecular diagnostics company. It plans to offer 3.8-M/shares in an expected price range of 11 to 13 to raise $45-M at a market cap of $123-M. Joint bookrunners for the offering are Stifel, Canaccord Genuity and Cantor Fitzgerald. Shares are scheduled to price Tuesday and begin trading Wednesday on the NAS under the symbol AGMX.

Avenue Financial Holdings Inc. is a bank holding company operating in Nashville, TN. The bank plans to offer 2.5-M/shares at an IPO price range of 11 to 13 to raise $30-M at a market cap of $120-M. The sole bookrunner for the offering is Keefe Bruyette Woods. Co-managers are Sandler O’Neill and Sterne Agee. Shares are scheduled to price Tuesday and begin trading Wednesday on the NAS under the symbol AVNU.

Sol-Wind Renewable Power L.P. is a MLP (master limited partnership) that plans to own, acquire, invest in and manage operating solar and wind power generation assets. The company plans to offer 8.7-M/shares in an expected price range of 19 to 21 raising $174-M, against a market cap of about $200-M. Joint bookrunners for the offering include UBS Investment Bank, Citigroup, Wells Fargo Securities, Credit Suisse, Deutsche Bank and Macquarie Capital. The IPO co-managers are Bonwick Capital, MFR Securities and Williams Capital Group. Shares are scheduled to price Tuesday and begin trading Wednesday on the New York Stock Exchange under the symbol SLWD.

Inovalon Holdings Inc. is a technology company offering a cloud-based analytics and data-driven intervention platform to improve clinical outcomes. The company plans to offer 22.2-M/shares at an expected price range of 21 to 24 to raise $500-M at a market cap of $3.25-B. The IPO joint bookrunners include Goldman Sachs, Morgan Stanley, Citigroup, Bank of America Merrill Lynch and UBS Investment Bank. Co-managers are Piper Jaffray, Wells Fargo Securities and William Blair. Shares are scheduled to price on Wednesday and begin trading Thursday the NAS under the symbol INOV.

Invitae Corp. plans to aggregate most of the world’s genetic tests into a single service. The company plans to offer 5.4-M/shares at an IPO price range of 13 to 15, raising about $75-M at a market cap of $417-M. Sole bookrunner for the offering is JP Morgan. Co-managers are Cowen and Leerink Partners. Shares are scheduled to price Wednesday and begin trading Thursday on the New York Stock Exchange under the symbol NVTA.

Bellerophon Therapeutics LLC is a clinical stage therapeutics company developing treatments for cardiopulmonary and cardiac diseases. The company plans to offer 4-M/shares in an expected price range of 14 to 16 to raise $60-M at a market cap of $178.5-M. Joint IPO bookrunners for the offering are Leerink Partners and Cowen. Co-managers are FBR Capital Markets and Suntrust Robinson Humphrey. Shares are scheduled to price Thursday and begin trading Friday on the NAS under the  symbol BLPH.

Great Ajax Corp. IPO is a mortgage REIT (real estate investment trust). It plans to offer 5.8-M/shares in a range of 15 to 17 to raise $93.4-M at a market cap of about $260-M. Joint bookrunners are FBR Capital Markets, Sterne Agee and Nomura Securities. Co-managers are Ladenburg Thalmann and MLV. Shares are scheduled to price Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol AJX.

If you are interested in trading in the IPO market, check into  the Live Trading Room and let us know, it is Free. Trade FX, Equities and Options with the World’s Leading Platform Open an account here , call us at 312 219 1354, or http://www.livetradingnews.com/contact-us#.VKhSAHt4VFc”>email us to get started

Have a terrific week.

HeffX-LTN

Paul Ebeling

The following two tabs change content below.

Paul Ebeling

Pattern Recognition Analyst, equities, commodities, forex
Paul Ebeling is best known for his work as writer and publisher of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly-regarded, weekly financial market letter, where he enjoys an international audience among opinion makers, business leaders, and respected organizations. Something of a pioneer in online stock market and commodities discussion and analysis, Ebeling has been online since 1994. He has studied and worked in the global financial and stock markets since 1984.

Trade FX, Equities and Options with the World's Leading Platform Open an account here , call us at 305 4904 116, or email us to get started.

Research 1 of 6

Super-Bubble3 mbsltn logo

Recent News